Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Mahaffey

Showing results (401-410 of 627) with videos related to

Pageof 63
Sort By:
JACC. Heart Failure|March 14, 2014
Heart failure complicating non-ST-segment elevation acute coronary syndrome: timing, predictors, and clinical outcomesMaria Cecilia Bahit, Renato D Lopes, Robert M Clare, et al.
Stroke|April 26, 2014
Rivaroxaban for stroke prevention in East Asian patients from the ROCKET AF trialKa Sing Lawrence Wong, Dai Yi Hu, Abraham Oomman, et al.
Circulation|May 11, 2012
Ticagrelor versus clopidogrel in patients with acute coronary syndromes and a history of stroke or transient ischemic attackStefan K James, Robert F Storey, Nardev S Khurmi, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|May 14, 2016
Hospitalizations in patients with atrial fibrillation: an analysis from ROCKET AFAdam D DeVore, Anne S Hellkamp, Richard C Becker, et al.
Circulation. Heart Failure|June 1, 2013
Efficacy and safety of rivaroxaban in patients with heart failure and nonvalvular atrial fibrillation: insights from ROCKET AFSean van Diepen, Anne S Hellkamp, Manesh R Patel, et al.
Journal of the American Heart Association|October 30, 2018
Selective Serotonin Reuptake Inhibitors and Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: An Analysis From the ROCKET AF TrialGene R Quinn, Anne S Hellkamp, Graeme J Hankey, et al.
Journal of Thrombosis and Thrombolysis|July 28, 2018
Early therapeutic persistence on dabigatran versus warfarin therapy in patients with atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registryLarry R Jackson, Sunghee Kim, Peter Shrader, et al.
American Heart Journal|September 29, 2014
Vorapaxar in patients with peripheral artery disease and acute coronary syndrome: insights from Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER)William Schuyler Jones, Pierluigi Tricoci, Zhen Huang, et al.
Circulation|December 18, 2015
Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial FibrillationJonathan P Piccini, Anne S Hellkamp, Jeffrey B Washam, et al.
European Heart Journal|September 25, 2015
The effect of cangrelor and access site on ischaemic and bleeding events: insights from CHAMPION PHOENIXJ Antonio Gutierrez, Robert A Harrington, James C Blankenship, et al.
Pageof 63

Showing results (401-410 of 627) with videos related to

Sort By:
Pageof 63
JACC. Heart Failure|March 14, 2014
Heart failure complicating non-ST-segment elevation acute coronary syndrome: timing, predictors, and clinical outcomesMaria Cecilia Bahit, Renato D Lopes, Robert M Clare, et al.
Stroke|April 26, 2014
Rivaroxaban for stroke prevention in East Asian patients from the ROCKET AF trialKa Sing Lawrence Wong, Dai Yi Hu, Abraham Oomman, et al.
Circulation|May 11, 2012
Ticagrelor versus clopidogrel in patients with acute coronary syndromes and a history of stroke or transient ischemic attackStefan K James, Robert F Storey, Nardev S Khurmi, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|May 14, 2016
Hospitalizations in patients with atrial fibrillation: an analysis from ROCKET AFAdam D DeVore, Anne S Hellkamp, Richard C Becker, et al.
Circulation. Heart Failure|June 1, 2013
Efficacy and safety of rivaroxaban in patients with heart failure and nonvalvular atrial fibrillation: insights from ROCKET AFSean van Diepen, Anne S Hellkamp, Manesh R Patel, et al.
Journal of the American Heart Association|October 30, 2018
Selective Serotonin Reuptake Inhibitors and Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: An Analysis From the ROCKET AF TrialGene R Quinn, Anne S Hellkamp, Graeme J Hankey, et al.
Journal of Thrombosis and Thrombolysis|July 28, 2018
Early therapeutic persistence on dabigatran versus warfarin therapy in patients with atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registryLarry R Jackson, Sunghee Kim, Peter Shrader, et al.
American Heart Journal|September 29, 2014
Vorapaxar in patients with peripheral artery disease and acute coronary syndrome: insights from Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER)William Schuyler Jones, Pierluigi Tricoci, Zhen Huang, et al.
Circulation|December 18, 2015
Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial FibrillationJonathan P Piccini, Anne S Hellkamp, Jeffrey B Washam, et al.
European Heart Journal|September 25, 2015
The effect of cangrelor and access site on ischaemic and bleeding events: insights from CHAMPION PHOENIXJ Antonio Gutierrez, Robert A Harrington, James C Blankenship, et al.
Pageof 63